We are Into Evidence

We are an advisory firm founded by experts in science, strategy and communications. We are dedicated to translating scientific data into impactful and meaningful evidence-based communications to the pharmaceutical industry and the healthcare sector.

We value science and we are driven by the
deep conviction that evidence must be
at the service of people’s health.

Vision & Missions

We aim to be a key player in creating a positive impact on people’s lives.

Our missions are:

  • Use evidence-based communications to guide health-related decision-making and drive sustainable behavior change
  • Produce compelling scientific content to targeted audiences
  • Build a communication bridge between healthcare stakeholders toward the common goal of improving people’s lives






PhD in Biotechnology from Paris Sud University (France)

Emna leads the Medical Communication department where she helps top biopharma clients develop strategic awareness campaigns and scientific communication programs dedicated to the 4Ps (payers, policy makers, prescribers and patients). Emna has also been involved in several projects in Market Access, Health Economics and Outcomes Research, developing value communications strategies, tailoring messages to local markets and supporting teams with marketing authorization and reimbursement submissions to health authorities. Emna is a recognized professional medical writer with an extensive record of peer-reviewed publications. As the former Editorial Manager of the Journal of Market Access and Health Policy, she has a thorough understanding of the publication process and has assisted several clients in getting their research published in high-impact journals. Prior to her career in Medical Writing, Emna was an assistant professor.



PhD in Immuno-Oncology from the University Claude Bernard of Lyon (France)

Ikbal has established herself within INTO EVIDENCE as a leader in the fields of medical marketing and strategic consultancy. She has been involved in several strategic programs to address the needs of prescribers and payers with top pharmaceuticals clients, aimed at identifying gaps and developing novel solutions facilitating access to innovative therapies across Europe and the MENA region. Before embarking into an entrepreneurship journey, Ikbal held several positions in the Market Access and Clinical trials fields. Prior to her career in the private sector, Ikbal dedicated her early career years to teaching as a part time lecturer at the Catholic University of Lyon and the Higher Institute of biotechnology of Monastir.